|
1
|
Messerschmitt PJ, Garcia RM, Abdul-Karim
FW, Greenfield EM and Getty PJ: Osteosarcoma. J Am Acad Orthop
Surg. 17:515–527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meyers PA, Schwartz CL, Krailo M,
Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W,
Gebhardt M, Goorin AM, et al: Osteosarcoma: A randomized,
prospective trial of the addition of ifosfamide and/or muramyl
tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J
Clin Oncol. 23:2004–2011. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R,
Vernon P, Cao L and Tang D: HMGB1 promotes drug resistance in
osteosarcoma. Cancer Res. 72:230–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu M, Jin H, Xu CX, Sun B, Song ZG, Bi WZ
and Wang Y: miR-382 inhibits osteosarcoma metastasis and relapse by
targeting Y box-binding protein 1. Mol Ther. 23:89–98. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu C and Tang DG: MicroRNA regulation of
cancer stem cells. Cancer Res. 71:5950–5954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
MacDonagh L, Gray SG, Breen E, Cuffe S,
Finn SP, O'Byrne KJ and Barr MP: BBI608 inhibits cancer stemness
and reverses cisplatin resistance in NSCLC. Cancer Lett.
428:117–126. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iliopoulos D, Lindahl-Allen M, Polytarchou
C, Hirsch HA, Tsichlis PN and Struhl K: Loss of miR-200 inhibition
of Suz12 leads to polycomb-mediated repression required for the
formation and maintenance of cancer stem cells. Mol Cell.
39:761–772. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song SJ, Poliseno L, Song MS, Ala U,
Webster K, Ng C, Beringer G, Brikbak NJ, Yuan X, Cantley LC, et al:
MicroRNA-antagonism regulates breast cancer stemness and metastasis
via TET-familydependent chromatin remodeling. Cell. 154:311–324.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin H, Luo S, Wang Y, Liu C, Piao Z, Xu M,
Guan W, Li Q, Zou H, Tan QY, et al: miR-135b stimulates
osteosarcoma recurrence and lung metastasis via notch and
Wnt/β-catenin signaling. Mol Ther Nucleic Acids. 8:111–122. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thayanithy V, Sarver AL, Kartha RV, Li L,
Angstadt AY, Breen M, Steer CJ, Modiano JF and Subramanian S:
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
Bone. 50:171–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hill KE, Kelly AD, Kuijjer ML, Barry W,
Rattani A, Garbutt CC, Kissick H, Janeway K, Perez-Atayde A,
Goldsmith J, et al: An imprinted non-coding genomic cluster at
14q32 defines clinically relevant molecular subtypes in
osteosarcoma across multiple independent datasets. J Hematol Oncol.
10:1072017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marcato P, Dean CA, Pan D, Araslanova R,
Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, et al:
Aldehyde dehydrogenase activity of breast cancer stem cells is
primarily due to isoform ALDH1A3 and its expression is predictive
of metastasis. Stem Cells. 29:32–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sullivan KE, Rojas K, Cerione RA, Nakano I
and Wilson KF: The stem cell/cancer stem cell marker ALDH1A3
regulates the expression of the survival factor tissue
transglutaminase, in mesenchymal glioma stem cells. Oncotarget.
8:22325–22343. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Duan JJ, Cai J, Guo YF, Bian XW and Yu SC:
ALDH1A3, a metabolic target for cancer diagnosis and therapy. Int J
Cancer. 139:965–975. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Biermann JS, Chow W, Reed DR, Lucas D,
Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, et
al: NCCN Guidelines Insights: Bone Cancer, Version 2.2017. J Natl
Compr Canc Netw. 15:155–167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Steffner RJ and Jang ES: Staging of bone
and soft-tissue sarcomas. J Am Acad Orthop Surg. 26:e269–e278.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yi H, Geng L, Black A, Talmon G, Berim L
and Wang J: The miR-487b-3p/GRM3/TGFβ signaling axis is an
important regulator of colon cancer tumorigenesis. Oncogene.
36:3477–3489. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
John AA, Prakash R and Singh D:
miR-487b-3p impairs osteoblastogenesis by targeting Notch-regulated
ankyrin-repeat protein (Nrarp). J Endocrinol. 241:249–263. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brabletz T, Jung A, Spaderna S, Hlubek F
and Kirchner T: Opinion: Migrating cancer stem cells-an integrated
concept of malignant tumour progression. Nat Rev Cancer. 5:744–749.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li F, Tiede B, Massagué J and Kang Y:
Beyond tumorigenesis: Cancer stem cells in metastasis. Cell Res.
17:3–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He H, Ni J and Huang J: Molecular
mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett.
7:1352–1362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sullivan KE, Cerione RA and Wilson KF:
ALDH1A3 in CSCs. Aging (Albany NY). 9:1351–1352. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu X, Chai S, Wang P, Zhang C, Yang Y,
Yang Y and Wang K: Aldehyde dehydrogenases and cancer stem cells.
Cancer Lett. 369:50–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
